6FG1
CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA32.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE MASSIF-1 |
Synchrotron site | ESRF |
Beamline | MASSIF-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2017-08-25 |
Detector | DECTRIS PILATUS3 2M |
Wavelength(s) | 0.966 |
Spacegroup name | P 4 21 2 |
Unit cell lengths | 189.101, 189.101, 87.259 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 87.260 - 2.030 |
R-factor | 0.267 |
Rwork | 0.266 |
R-free | 0.28500 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4irz 4NM4 and 3X3F |
RMSD bond length | 0.008 |
RMSD bond angle | 1.080 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | MOLREP |
Refinement software | BUSTER (2.11.7) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 87.600 | 2.070 |
High resolution limit [Å] | 2.030 | 2.030 |
Rmerge | 0.132 | |
Number of reflections | 81847 | |
<I/σ(I)> | 11.9 | |
Completeness [%] | 99.8 | |
Redundancy | 8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 292 | Na2 Malonate 1.7M - pH6 |